402 related articles for article (PubMed ID: 21248786)
21. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
[TBL] [Abstract][Full Text] [Related]
22. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
Simms LA; Algar EM; Smith PJ
Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
[TBL] [Abstract][Full Text] [Related]
23. The many facets of the Wilms' tumour gene, WT1.
Hohenstein P; Hastie ND
Hum Mol Genet; 2006 Oct; 15 Spec No 2():R196-201. PubMed ID: 16987884
[TBL] [Abstract][Full Text] [Related]
24. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
[TBL] [Abstract][Full Text] [Related]
25. Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
Fukuzawa R; Heathcott RW; More HE; Reeve AE
J Clin Pathol; 2007 Sep; 60(9):1013-6. PubMed ID: 17172473
[TBL] [Abstract][Full Text] [Related]
26. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
[TBL] [Abstract][Full Text] [Related]
27. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics of Wilms' tumour.
Tay JS
J Paediatr Child Health; 1995 Oct; 31(5):379-83. PubMed ID: 8554853
[TBL] [Abstract][Full Text] [Related]
29. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
30. RNA processing. Wilms' tumour--the splicing connection?
Lamond AI
Curr Biol; 1995 Aug; 5(8):862-5. PubMed ID: 7583142
[TBL] [Abstract][Full Text] [Related]
31. New tumour suppressor linked to Wilms' tumour.
Bagchi S
Lancet Oncol; 2007 Feb; 8(2):102. PubMed ID: 17290504
[No Abstract] [Full Text] [Related]
32. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
[TBL] [Abstract][Full Text] [Related]
33. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
34. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
35. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
36. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour.
Miyagawa K; Kent J; Moore A; Charlieu JP; Little MH; Williamson KA; Kelsey A; Brown KW; Hassam S; Briner J; Hayashi Y; Hirai H; Yazaki Y; van Heyningen V; Hastie ND
Nat Genet; 1998 Jan; 18(1):15-7. PubMed ID: 9425891
[No Abstract] [Full Text] [Related]
37. Wilms' tumour--a case of disrupted development.
Miyagawa K; Kent J; Schedl A; van Heyningen V; Hastie ND
J Cell Sci Suppl; 1994; 18():1-5. PubMed ID: 7883783
[TBL] [Abstract][Full Text] [Related]
38. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.
Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN
World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617
[TBL] [Abstract][Full Text] [Related]
39. Wilms' tumour: reconciling genetics and biology.
Van Heyningen V; Hastie ND
Trends Genet; 1992 Jan; 8(1):16-21. PubMed ID: 1369730
[TBL] [Abstract][Full Text] [Related]
40. Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.
Lai YC; Lu MY; Wang WC; Hou TC; Kuo CY
Int J Exp Pathol; 2022 Jun; 103(3):121-128. PubMed ID: 35436013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
